ArticleBioMed research international2025
Deciphering B Cell Heterogeneity and Pathogenic Mechanisms in Osteoporosis Through Single-Cell RNA Sequencing.
Article in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cellular senescence and the SASP in skeletal ageing: convergent mechanisms of progressive bone loss in osteoporosis.Biogerontology · 2026Review
- Deciphering B Cell Heterogeneity and Pathogenic Mechanisms in Osteoporosis Through Single-Cell RNA Sequencing.BioMed research international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoporosis is characterized by reduced bone mineral density and disrupted bone microstructure, leading to an increased risk of fractures. This study aimed to investigate the role of B cell subpopulations in osteoporosis and their effects on bone metabolism using single-cell RNA sequencing. Methods: Single-cell RNA sequencing data from primary human femoral head tissue cells of three osteoporosis patients and one non-osteoporosis patient were obtained from the GEO dataset (GSE169396). Data preprocessing, integration, dimensionality reduction, clustering, and annotation were conducted using the Seurat package in R. Enrichment analysis, cell trajectory analysis, and intercellular communication analysis were then applied to investigate the role of B cells and the signaling pathways within B cell subpopulations in osteoporosis. Results: We identified six distinct B cell subpopulations, and further analysis revealed a higher proportion of precursor B cells in osteoporosis patients compared to the normal group. Functional studies indicated that B cells contribute to the progression of osteoporosis through inflammatory activation and the unfolded protein response. Cell communication analysis among these B cell subpopulations demonstrated markedly enhanced intercellular signaling in osteoporosis patients relative to the normal group. Notably, two critical signaling pathways, MIF-(CD74+CXCR4) and LGALS9-CD45, were identified as potential key regulators driving the progression of osteoporosis. Conclusion: This study underscores the heterogeneity and functions of B cells in osteoporosis, highlighting two signaling pathways implicated in disease progression. These findings offer novel insights into osteoporosis pathogenesis and suggest potential therapeutic targets for its treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.